In a surprising turn of events, Regeneron has announced its acquisition of 23andMe for $256 million following the company's bankruptcy. The pharma giant aims to leverage 23andMe's vast customer data for drug discovery while prioritizing privacy and security.
Sir Keir Starmer's recent Brexit deal sparks debate on its significance. While some see it as a step forward, others criticize it as a mere extension of old issues. Will this reshape UK-EU relations?
World leaders gathered in Rome for Pope Leo XIV's grand installation, signaling a new approach to diplomacy and peace in the wake of global conflicts. Will he succeed in uniting nations?
Pope Leo XIV, the first American pope, pledges to foster unity and peace within the Catholic Church during his inaugural Mass attended by dignitaries and pilgrims alike.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
President Trump's budget proposal for 2026 reveals a surprising 24% cut in NASA funding, potentially jeopardizing the Artemis program and favoring commercial space companies like SpaceX and Blue Origin.
In a historic move, the FDA has approved the first-ever blood test designed to diagnose Alzheimer's disease, marking a significant advancement in early detection and treatment options for patients.
In a groundbreaking move, Brock Purdy secures a five-year, $265 million contract with the San Francisco 49ers, marking a new chapter for the franchise quarterback after remarkable playoff success.
SpaceX has successfully launched 28 new Starlink satellites, enhancing global internet connectivity. This mission marks another milestone with the Falcon 9 rocket's fourth flight, landing safely after deployment.
OpenAI announces the rollout of GPT-4.1 for ChatGPT users, enhancing coding tasks with a massive context token window and improved speed. Free users are excluded, but more access is coming soon!
